sameAs
TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated DonorsDonor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched DonorsStudy of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)Oral Clofarabine for Relapsed/Refractory Non-Hodgkin LymphomaClofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic SyndromesReduced Intensity AlloTransplant For OsteopetrosisCombination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesClofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease2 Arm Study of Clofarabine IV in MDS PatientsClofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous TreatmentA Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaClofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative NeoplasmThe Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid LeukemiaFludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesClofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) AdultsPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchMulti-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 RegimenNHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic LymphomaClofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic SyndromesClofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual DiseaseAllogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDSClofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic SyndromesClofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid TumorsClofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid LeukemiaCombination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive MutationsClofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic SyndromeClofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALLClofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell TransplantHLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic MalignanciesPK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute LeukemiasClofarabine With Cytarabine for Patients With Minimal Residual Disease Positive LeukemiaEntinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic LeukemiaA Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Clofarabine
@vi
Clofarabină
@ro
Klofarabin
@sh
Klofarabin
@sr
clofarabine
@en
clofarabine
@fr
klofarabin
@nn
type
label
Clofarabine
@vi
Clofarabină
@ro
Klofarabin
@sh
Klofarabin
@sr
clofarabine
@en
clofarabine
@fr
klofarabin
@nn
altLabel
(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
@en
(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
@en
2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine
@en
2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine
@en
2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine
@en
2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine
@en
CAFdA
@en
CL-F-Ara-a
@en
Cl-F-Ara-A
@en
Cl-F-araA
@en
prefLabel
Clofarabine
@vi
Clofarabină
@ro
Klofarabin
@sh
Klofarabin
@sr
clofarabine
@en
clofarabine
@fr
klofarabin
@nn